Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Xylofuranosly-containing-nucleoside-phosphoramidites-and-polynucleotides

 Methods of screening for compounds that derepress or increase telomerase activity
We claim: 1. Method for screening for a telomerase derepression agent, the method comprising the ...


 Oral vaccines
What is claimed is: 1. A protein conjugate comprising an immunogen covalently linked to a carrier ...


 Method for identifying validated target and assay combinations for drug development
The invention relates to methods that couple the validation of a target (see Definitions) for drug ...


 Synthetic DNA sequences having enhanced expression in monocotyledonous plants and method for preparation thereof
OF THE PREFERRED EMBODIMENTS The following definitions are provided for clarity of the terms used ...


 Synthetic oligomers having chirally pure phoshonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages
OF THE INVENTION The phosphonate internucleosidyl linkages used in oligomers of the present ...


 Sequence specific DNA binding by p53
It is an object of the invention to provide a method for detecting the presence of wild-type p53 ...


 C-pyrazole A.sub.2A receptor agonists
We claim: 1. A composition of matter having the formula: ##STR00032## 2. A method for stimulating ...


 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus
Advantageously, the present invention provides E1 expressing cell lines that are stable, can be ...


 Method for investigating the condition of a bacterial suspension through frequency profile of electrical admittance
We claim: 1. A method of investigating the condition of a suspension of bacteria in a fluid medium, ...


 Apparatus and methods for electroporation and electrofusion
To achieve the objects of this invention, a method of electroporation of a first type of cells is ...


 Xylofuranosly-containing nucleoside phosphoramidites and polynucleotides

Details
Inventors: Matulic-Adamic, Jasenka; Beigelman, Leonid;
Assignee: Ribozyme Pharmaceuticals, Inc. (Boulder, CO)
Primary Examiner: Houtteman; Scott W.
Assistant Examiner:
Attorney, Agent or Firm: McDonnell Boehnen Hulbert & Berghoff

Novel xylo nucleoside or xylo nucleotide analogs, polynucleotides comprising xylo nucleotide substitution, processes for their synthesis and incorporation into polynucleotides.

DETAILED DESCRIPTION What is claimed is: 1.
A compound having the formula I: ##STR5## wherein, R.
sub.
1 is OH, O--R.
sub.
3, C--R.
sub.
3, halo, NHR.
sub.
4, ONHR.
sub.
5 or ON.
dbd.
R.
sub.
6, wherein R.
sub.
3 is independently a moiety selected from a group consisting of alkyl, alkenyl, alkynyl, aryl, alkylaryl, carbocyclic aryl, heterocyclic aryl, amide and ester; R.
sub.
4 is independently a moiety selected from a group consisting of alkyl (C1-22), acyl (C1-22), substituted or unsubstituted aryl), or OCH.
sub.
2 SCH.
sub.
3 (methylthiomethyl); R.
sub.
5 is independently a moiety selected from a group consisting of H, aminoacyl group, peptidyl group, biotinyl group, cholesteryl group, lipoic acid residue, retinoic acid residue, folic acid residue, ascorbic acid residue, nicotinic acid residue, 6-aminopenicillanic acid residue, 7-aminocephalosporanic acid residue, alky, alkenyl, alkynyl, aryl, alkylaryl, carbocyclic aryl, heterocyclic aryl, amide or ester; and R.
sub.
6 is independently pyridoxal residue, pyridoxal-5-phosphate residue, 13-cis-retinal residue, 9-cis-retinal residue, alkyl, alkenyl, alkynyl, alkylaryl, carbocyclic alkylaryl, or heterocyclic alkylaryl; B is independently a nucleotide base or hydrogen; X is independently a phosphorus-containing group; and R.
sub.
2 is independently a blocking group or a phosphorus-containing group.
2.
The compound of claim 1, wherein said compound is a nucleotide.
3.
The compound of claim 1, wherein said compound is a nucleotide-triphosphate.
4.
A polynucleotide comprising the compound of claim 1 at one or more positions.
5.
The polynucleotide of claim 4, wherein said polynucleotide is an enzymatic nucleic acid.
6.
The enzymatic nucleic acid of claim 5, wherein said nucleic acid is in a hammerhead configuration.
7.
The enzymatic nucleic acid of claim 6, where in said nucleic acid is in a hairpin configuration.
8.
The enzymatic nucleic acid of claim 6, wherein said nucleic acid is in a hepatitis delta virus, group I intron, VS RNA, group II intron or RNase P RNA configuration



Related patents
  Substituted indazole-O-glucosides
OF THE INVENTION All diabetics, regardless of their genetic and environmental backgrounds, have in common an apparent lack of insulin or inadequate insulin function. B...
  Production in Escherichia coli of extracellular Serratia spp. hydrolases
We claim: 1. A method of producing an extracellular hydrolytic Serratia spp. enzyme selected from the group consisting of exocellular nuclease, exocellular phospholipase ...
  Modular assembly of antibody genes, antibodies prepared thereby and use
What is claimed is: 1. A polynucleotide molecule encoding an immunoglobulin fragment, said immunoglobulin fragment comprising a first DNA sequence encoding a first ...
  Cytoplasmic bacteriophage display system
The present invention relates, in one aspect, to a display vector comprising DNA encoding a portion of a structural protein from a cytoplasmic bacteriophage, joined ...
  Diagnosis of alzheimer disease stage by mononuclear cell cytokine secretions
AND ADVANTAGES According to the present invention, a method of diagnosing and determining the disease stage or severity of a degenerative disease of the central nervous ...
  Polyvalent display libraries
I. General The present invention is directed to inter alia two related but self-sufficient improvements in conventional display methods. The first improvement provides ...
  Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus
OF THE INVENTION A. Definitions Amino Acid Residue: An amino acid formed upon chemical digestion (hydrolysis) of a polypeptide at its peptide linkages. The amino acid ...
  Pharmaceutical and diagnostic business systems and methods
Improved business methods, devices, and systems for utilizing genetic information are provided. According to one embodiment of the invention a business method is ...
  Addition compound of a nucleotide and an amino acid and the use thereof in protection against actinic radiation
I claim: 1. A topical composition for protection against actinic radiation, comprising a dermatologically acceptable inert carrier suitable for application to human skin,...
  Method of differential display of exposed mRNA by RT/PCR
We claim: 1. A method of comparing the presence or level of individual mRNA molecules in two or more nucleic acid samples, comprising the steps of: providing a first ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved